Back to Results
First PageMeta Content
Infectious diseases / Bacterial diseases / Pneumonia / Staphylococcaceae / Basilea Pharmaceutica / Healthcare-associated pneumonia / Methicillin-resistant Staphylococcus aureus / Nosocomial infection / Ventilator-associated pneumonia / Medicine / Microbiology / Bacteria


PRESS RELEASE Swissmedic approves Basilea’s antibiotic Zevtera® (ceftobiprole medocaril) for the treatment of pneumonia Basel, Switzerland, December 22, 2014 – Basilea Pharmaceutica Ltd. (SIX: BSLN) reports that the
Add to Reading List

Open Document

File Size: 48,80 KB

Share Result on Facebook
UPDATE